Zhongjie Pu is the founder of Lepu Bio. Latest round: Series C. Backed by Sunshine Life Insurance, Ronghui Capital, Ping An Capital. Based in Beijing, China.
Zhongjie Pu is the founder of Lepu Biopharma, a biopharmaceutical company established in early 2018. The company focuses on oncology therapeutics, particularly cancer immunotherapy and targeted drugs. Lepu Biopharma completed a RMB 1.291 billion Series B financing and later secured Series C financing from Vivo Capital and Shanghai Bio-medical Fund. The funds are used to accelerate R&D, clinical trials, and product marketing.
Full founder directory · Investor directory · Company funding database · Fundraising library